Gender-specific association of psychological distress with cardiovascular risk scores

Figures & data

Table I. Demographic, clinical and biochemical characteristics and use of medication of the study subjects.

Characteristics	Male (n=399)	Female (n=500)	p-value
Demographic:
Age, mean (SD), years	46 (6)	46 (6)	0.61
Body mass index, mean (SD), kg/m ^2	26.6 (3.7)	26.4 (5.2)	0.42
Smoking, n (%)	136 (34)	112 (22)	<0.001
Clinical:
Blood pressure, mean (SD), mmHg:
Systolic	137 (17)	131 (18)	<0.001
Diastolic	84 (10)	80 (10)	<0.001
Biochemical:
Total cholesterol, mean (SD), mmol/l	5.8 (1.1)	5.7 (1.0)	0.02
HDL cholesterol, mean (SD), mmol/l	1.3 (0.3)	1.5 (0.3)	<0.001
Total triglycerides, mean (SD), mmol/l	1.7 (1.3)	1.2 (0.6)	<0.001
Fasting plasma glucose, mean (SD), mmol/l	6.0 (0.9)	5.7 (0.6)	<0.001
Medication, n (%)
Anti-hypertensive medication	41 (10)	43 (9)	0.39
Cholesterol-lowering medication	12 (3)	6 (1)	0.06
Anti–diabetic medication	32 (8)	26 (5)	0.09

Figure 1. Gender-specific association of GHQ with European CVD score and Framingham CVD risk. Whiskers show 95% confidence intervals.